Literature DB >> 6255741

Inhibition of hepatitis B Dane particle DNA polymerase activity by pyrophosphate analogs.

E Nordenfelt, B Oberg, E Helgstrand, E Miller.   

Abstract

A DNA polymerase is associated with the core of the so-called Dane particles. The probability that this is the hepatitis B viral DNA polymerase offers the possibility of preventing hepatitis B multiplication by selective inhibition of this enzyme. We have previously reported that trisodium phosphonoformate (PFA) inhibits Dane particle DNA polymerase. Fifteen compounds with structural similarity to PFA and pyrophosphate have now been tested for inhibition of hepatitis B virus DNA polymerase in an attempt to define the structural requirement for the inhibition. Active structures have two acid groups at close proximity of which at least one is a phosphono group. Phosphonoformate and hypophosphare were the two most active inhibitors. The Ki value for PFA was 7.2 microM when dTTP was used as variable substrate, and the mechanism of inhibition was non-competitive. Phosphonoformate caused rapid shut-off of the polymerase reaction, indicating that it might inhibit elongation. The efficient inhibition of hepatitis B virus DNA polymerase by PFA and its low toxicity suggest that it could be used to inhibit hepatitis B virus multiplication in vivo.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6255741     DOI: 10.1111/j.1699-0463.1980.tb02623.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand B        ISSN: 0105-0656


  4 in total

1.  Comparison of properties of woodchuck hepatitis virus and human hepatitis B virus endogenous DNA polymerases.

Authors:  O Hantz; T Ooka; L Vitvitski; C Pichoud; C Trepo
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

2.  Differential inhibition of DNA polymerase and RNase H activities of the reverse transcriptase by phosphonoformate.

Authors:  M Margalith; H Falk; A Panet
Journal:  Mol Cell Biochem       Date:  1982-03-19       Impact factor: 3.396

3.  Treatment of chronic replicative hepatitis B virus infection with short-term continuous infusion of foscarnet.

Authors:  R Schvarcz; B G Hansson; J O Lernestedt; O Weiland
Journal:  Infection       Date:  1994 Sep-Oct       Impact factor: 3.553

4.  Mechanistic characterization and molecular modeling of hepatitis B virus polymerase resistance to entecavir.

Authors:  Ann W Walsh; David R Langley; Richard J Colonno; Daniel J Tenney
Journal:  PLoS One       Date:  2010-02-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.